Showing 1381 - 1400 of 2006 results
ANSTO has just completed the largest coordinated safety and security review of the OPAL multi-purpose research reactor, as part of a new a world-leading approach to assessing performance
ANSTO may provide travel and accommodation support to successful grant applicants from AINSE member organisations. Travel funds granted are to be used solely to cover the majority of the cost to travel to Sydney.
The Platypus instrument can be used to study all-manner of surface-science and interface problems, particularly related to magnetic recording materials and for polymer coatings, biosensors and artificial biological membranes.
The User Advisory Committee (UAC) is an independent group that provides advice to ANSTO Australian Synchrotron (AS) senior management on issues from a user perspective.
The Australian Synchrotron has an on-site Guesthouse for users and AS guests.
ANSTO is part of a contingent showcasing Australian science at the Australian Pavilion at the World Expo Osaka in October.
A groundbreaking international study has provided new insights into global fossil methane emissions, using innovative multi-isotopic atmospheric measurements.
Targeted research to improve knowledge of past and present climate and the evolution of landscape.
Under the Government Procurement (Judicial Review) Act 2019 (Cth) ANSTO will publish Public Interest Certificates (PICs) for the current financial year where appropriate.
Shift in the treatment of blood cancers taking place.
Soft X-ray experiments used to characterise new thin film topological Dirac Semimetal.
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
Radiocarbon dating at ANSTO has supported research that vastly extends the known timeline of the Aboriginal occupation of South Australia’s Riverland region.
Whilst at ANSTO’s Australian Synchrotron today, Prime Minister Scott Morrison announced new funding for the Australian Precision Medicine Enterprise (APME) Project. The Australian Government will contribute $23m in grant funding under the Manufacturing Collaboration Stream of the Modern Manufacturing Initiative (MMI) towards the $71.2m project.